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In past, our knowledge about human genetic variation was limited to mainly the rare changes in the number and structure of chromosomes which included aneuploidies, heteromorphisms, rearrangements and other polymorphism, large enough to be visualized by microscopic techniques. With the advances in molecular biology came the single nucleotide polymorphism (SNPs) in DNA, which is the most prevalent type of genetic variation and identified mainly using PCR-based methods. Recently, copy number variants (CNVs) are highlighted to be a significant source of human genetic variation accounting for disease susceptibility and disease development, thus revealing the gap between long-recognized microscopic chromosomal alterations and invisible changes at nucleotide level. Copy number variation (CNV) can be defined as segments of DNA ranging in size from kilobases (larger than 1 kb) to several megabases (Mb) varying in copy number in comparison to the reference genome. Deletions, duplications, segmental duplication, insertions, and translocations all result in CNVs. Rapid advances in the technologies have enabled the detection of CNVs on larger scale. Thus, depending on the method of detection, it has been estimated that CNVs may cover about 12% of the human genes. 
The discovery of submicroscopic copy-number variations (CNVs) present in human genome has dramatically changed our perspective on DNA structural variation and development of disease. Advancement in technology has allowed for the analysis of CNVs in thousands of individuals with or without a specific disease. Till date many researchers have addressed the presence of CNVs in the human genome and their association with common human diseases including neuropsychiatric, autoimmune, infectious, and many more, whereas others found evidence that CNVs are not associated with common diseases. CNVs and their involvement in disease susceptibility and drug response have been widely studied in other populations but not to any extent in Indian population. Therefore, the main aim of our study was to evaluate the distribution of copy number variable genes in Indian population and their link, if any, to health, disease and drug response. Based on our selection criteria, few copy number variable genes were selected and studied for their role in human diseases like cancer (breast and head and neck cancer), psoriasis, asthma, HIV-1/AIDS and others. In this study, the candidate copy number variable genes studied, MTUS1 for breast cancer and head and neck cancer; LCE3C and LCE3B for psoriasis susceptibility; GSTT1 and GSTM1 for asthma susceptibility; and CCL3L1 for HIV-1/AIDS susceptibility. The copy number frequency distribution of FCGR3B and SULT1A1 involved in SLE susceptibility and drug metabolism respectively, was evaluated in the Indian population. In this study CNV for these selected genes were analyzed in 100 – 280 normal healthy individuals from Western Indian population and in variable number of patients suffering from respective diseases. In many cases the frequency of CNV variants was significantly different in Indian population as compared to studies reported in other population. Also, significant inter-ethnic differences were observed in the distribution of variants in comparison to other population. The association of the MTUS1 deletion variant in susceptibility or decreased risk to head and neck and breast cancer was evaluated where indicative correlation with deletion of MTUS1 gene was observed only in breast cancer patients. Further, the significant association between CCL3L1 copy number and risk to HIV-1 is observed in our study. The sample size in the above mentioned study was very small, therefore the results needs to be further validated in large sample size before making firm conclusion about the link between the CNV of MTUS1 and CCL3L1 and risk to breast cancer and HIV-1 respectively. The discovery of submicroscopic copy-number variations (CNVs) present in human genome has dramatically changed our perspective on DNA structural variation and development of disease. Advancement in technology has allowed for the analysis of CNVs in thousands of individuals with or without a specific disease. Till date many researchers have addressed the presence of CNVs in the human genome and their association with common human diseases including neuropsychiatric, autoimmune, infectious, and many more, whereas others found evidence that CNVs are not associated with common diseases. CNVs and their involvement in disease susceptibility and drug response have been widely studied in other populations but not to any extent in Indian population. Therefore, the main aim of our study was to evaluate the distribution of copy number variable genes in Indian population and their link, if any, to health, disease and drug response. Based on our selection criteria, few copy number variable genes were selected and studied for their role in human diseases like cancer (breast and head and neck cancer), psoriasis, asthma, HIV-1/AIDS and others. In this study, the candidate copy number variable genes studied, MTUS1 for breast cancer and head and neck cancer; LCE3C and LCE3B for psoriasis susceptibility; GSTT1 and GSTM1 for asthma susceptibility; and CCL3L1 for HIV-1/AIDS susceptibility. The copy number frequency distribution of FCGR3B and SULT1A1 involved in SLE susceptibility and drug metabolism respectively, was evaluated in the Indian population. In this study CNV for these selected genes were analyzed in 100 – 280 normal healthy individuals from Western Indian population and in variable number of patients suffering from respective diseases. In many cases the frequency of CNV variants was significantly different in Indian population as compared to studies reported in other population. Also, significant inter-ethnic differences were observed in the distribution of variants in comparison to other population. The association of the MTUS1 deletion variant in susceptibility or decreased risk to head and neck and breast cancer was evaluated where indicative correlation with deletion of MTUS1 gene was observed only in breast cancer patients. Further, the significant association between CCL3L1 copy number and risk to HIV-1 is observed in our study. The sample size in the above mentioned study was very small, therefore the results needs to be further validated in large sample size before making firm conclusion about the link between the CNV of MTUS1 and CCL3L1 and risk to breast cancer and HIV-1 respectively.  


